Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 15/20 | 1.00 |
| ▸ | CYTH2 | Q99418 | 1/20 | 0.77 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.72 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.72 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | METAP2 | P50579 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2436550 | 0.87 | FFAR4 (0.77) | FFAR4CYTH2GABRG2GABRB3GABRA3 | |
| SCHEMBL23054298 | 0.87 | CYTH2 (1.00) | FFAR4CYTH2GABRG2GABRB3GABRA3 | |
| SCHEMBL812686 | 0.86 | FFAR4 (1.00) | FFAR4CYTH2GABRG2GABRB3GABRA3 | |
| SCHEMBL10884844 | 0.84 | TSHR (0.73) | FFAR4CYTH2KMT2APOLB | |
| SCHEMBL19357604 | 0.84 | FFAR4 (1.00) | FFAR4CYTH2GABRG2GABRB3GABRA3 | |
| SCHEMBL14409388 | 0.83 | FFAR4 (0.70) | FFAR4CYTH2GABRG2GABRB3GABRA3 | |
| SCHEMBL10623079 | 0.83 | FFAR4 (0.70) | FFAR4CYTH2GABRG2GABRB3GABRA3 | |
| SCHEMBL12789657 | 0.82 | FFAR4 (0.79) | FFAR4CYTH2GABRG2GABRB3GABRA3 | |
| SCHEMBL29048726 | 0.81 | FFAR4 (0.77) | FFAR4KMT2ATP53 | |
| SCHEMBL25767130 | 0.80 | FFAR4 (0.66) | FFAR4CYTH2GABRG2GABRB3GABRA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7646457-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-7646457-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-20070182895-A1 | Liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070182895-A1 | Liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-7037990-B2 | Transition metal complexes in the controlled synthesis of polyolefins substituted with functional groups | NIPPON SYNTHETIC CHEMICAL COMPANY (JP) | 2006-05-02 | — | — | US | disclosed |
| WO-2004063229-A2 | TRANSITION METAL COMPLEXES IN THE CONTROLLED SYNTHESIS OF POLYOLEFINS SUBSTITUTED WITH FUNCTIONAL GROUPS | THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-07-29 | — | — | WO | disclosed |
| US-20040132936-A1 | Transition metal complexes in the controlled synthesis of polyolefins substituted with functional groups | NIPPON SYNTHETIC CHEMICAL COMPANY (JP) | 2004-07-08 | — | — | US | disclosed |
| US-20040132610-A1 | Transition metal complexes in the controlled synthesis of polyolefins substituted with functional groups | SRI INTERNATIONAL | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132610-A1 | Transition metal complexes in the controlled synthesis of polyolefins substituted with functional groups | ADH1C, ELOVL6, TRRAP | FFAR4 1073/4885CYTH2 4257/4885GABRG2 1606/4885 |
| US-20040132936-A1 | Transition metal complexes in the controlled synthesis of polyolefins substituted with functional groups | ADH1C, ELOVL6, TRRAP | FFAR4 1073/4885CYTH2 4257/4885GABRG2 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.